Bioworld Financial Watch articles from February 2004

Bioworld Financial Watch archives from February 2004

In U.S., overseas, companies eyeing biogenerics windfall.
February 2, 2004... Say "generics" to a roomful of biotechnology profiteers and watch the anxiety spread like a drop of ink in water. The threat has been a long time coming, but it's almost here. Already the FDA is trying to figure out how to manage generic...

10 biggest U.S. gainers for the week.
February 2, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Deltagen 100.00 QLTPhotoTher 4.56 QLT PhotoTher 24.57 Immtech 2.86 DUSA Pharma 23.49 Invitrogen 2.84 MacroChem ...

10 biggest U.S. losers for the week.
February 2, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Cygnus -30.38 Gilead Sciences -10.94 Exact Sciences -20.78 Digene -4.14 Zonagen -20.76 United Thera...

U.S. public offering performance by underwriter: Jan. 1--Dec. 31, 2003 *.
February 2, 2004... U.S. Public Offering Performance By Underwriter: Jan. 1 - Dec. 31, 2003 * UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS JAN. 1 - DEC. 31, 2003: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY GROSS PROCEEDS * Underwriter ...

BioWorld stock report for public biotechnology companies.
February 2, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 1/23 1/30 Aastrom Biosci ASTM 1.65 1.63 Abgenix ABGX 15.6 ...

Eyetech's strong IPO performance provides momentum to filed bids.
February 9, 2004... Any pupil of biotech will tell you: One eyebrow-raising initial public offering does not an IPO wave make. Still, observers held hopes that if Eyetech Pharmaceuticals Inc. came through with a solid pricing and decent aftermarket performance,...

10 biggest U.S. gainers for the week.
February 9, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) AEterna 46.28 Idexx Labs 2.95 DOR BioPharma 34.15 Alexion Pharma 2.20 Orchid 29.44 Invitrogen 1.89...

10 biggest U.S. losers for the week.
February 9, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Seattle Genetics -20.04 Digene -5.05 Cyanotech -16.75 ICOS -5.05 Large Scale -13.64 NPS Pharma ...

Public financing of biotechnology: January 2004.
February 9, 2004... Public Financing Of Biotechnology: January 2004 I. COMMENCED TRADING IN DECEMBER Company Date Date Shares/ Price Shares Out (Symbol) (#) Filed Comm. Units (M) (M) (@) INITIAL...

Other financings of public biotechnology companies: January 2004.
February 9, 2004... Other Financings Of Public Biotechnology Companies: January 2004 TOTAL: $452.95M Company Type Of Number Of Amount (Symbol) (#) Financing Shares, Raised ...

Venture capital and corporate investments in biotechnology companies: January 2004.
February 9, 2004... Venture Capital And Corporate Investments In Biotechnology Companies: January 2004 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $444.26M Company Location Date Amt. (M) Athenix Corp. ...

Money raised by biotech in 2004: January.
February 9, 2004... Money Raised By Biotech In 2004: January Type of financing Jan. ($M) Total ($M) Public offerings 352.07 352.07 Private biotechs 444.26 444.26 Public/other 452.95 452.95...

BioWorld Stock report for public biotechnology companies.
February 9, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change Vol 1/30 2/6 WK YTD (000) Aastrom Biosci ASTM ...

Upstream partnering trend would bode well for early stage firms.
February 16, 2004... VANCOUVER, British Columbia -- The fundamentals of deal-making got marquee billing at last week's BioPartnering North America conference, which for two days provided a forum to illustrate essentials associated with the process. More than...

10 biggest U.S. gainers for the week.
February 16, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Avax Technol 147.06 MGI Pharma 4.45 Valentis 60.29 Cephalon 4.16 Miravant 39.33 Pharmion 3.48...

10 biggest U.S. losers for the week.
February 16, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) CuraGen -22.04 Invitrogen -2.55 Northwest BioThera -16.00 Celgene -2.03 Advancis -13.47...

Clinical trials update: January 2004.
February 16, 2004... Clinical Trials Update: January 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Alexion Eculizumab A humanized monoclonal antibody Pharmaceuticals ...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: January 2004.
February 16, 2004... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations and Approvals: January 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Amgen Inc. Enbrel ...

FDA submissions, approvals and other actions: January 2004.
February 16, 2004... FDA Submissions, Approvals And Other Actions: January 2004 Company * Product Description (Country; Symbol) CANCER Callisto Atiprimod Drug designed to inhibit Pharmaceuticals ...

BioWorld stock report for public biotechnology companies.
February 16, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 2/6 2/13 Aastrom Biosci ASTM 1.49 1.51 Abgenix ...

Connetics evolves with Soriatane purchase; psoriasis market grows.
February 23, 2004... Connetics Corp.'s president and CEO Thomas Wiggans called it a "transforming event." Known for Olux and Luxiq, the marketed duo of foams to treat scalp disorders, his company this month entered an agreement to buy exclusive U.S. rights to F....

Biotech--big pharma collaborations: new agreements, Nov. 21, 2003-Feb. 19, 2004 #.
February 23, 2004... Biotech - Big Pharma Collaborations: New Agreements, Nov. 21, 2003 - Feb. 19, 2004 # Biotech Co. * Pharma Co. Type/Product Area (Country; Symbol) (Country) Access Wyeth Agreement...

Manufacturing, marketing and distribution agreements between Biotech and Pharmaceutical Companies: Nov. 21, 2003-Feb. 19, 2004 #.
February 23, 2004... Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Nov. 21, 2003 - Feb. 19, 2004 # Biotech Co.* Pharma Co. Product (Country; Symbol) (Country) Accelrys Inc. ...

Biotech--big pharma collaborations: modified and terminated agreements, Nov. 21, 2003-Feb. 19, 2004 #.
February 23, 2004... Biotech - Big Pharma Collaborations: Modified And Terminated Agreements, Nov. 21, 2003 - Feb. 19, 2004 # Biotech Co. * Pharma Co. Change from original (Country; Symbol) (Country) agreement I. MODIFIED...

BioWorld stock report for public biotechnology companies.
February 23, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 2/13 2/20 Aastrom Biosci ASTM 1.51 1.47 Abgenix ...